Cargando…
Reply to: Probiotics for the Prevention of COVID-19 Sequelae
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376338/ https://www.ncbi.nlm.nih.gov/pubmed/35999061 http://dx.doi.org/10.1016/j.arcmed.2022.08.005 |
_version_ | 1784768145906466816 |
---|---|
author | KURIAN, SHILIA JACOB MIRAJ, SONAL SEKHAR |
author_facet | KURIAN, SHILIA JACOB MIRAJ, SONAL SEKHAR |
author_sort | KURIAN, SHILIA JACOB |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9376338 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93763382022-08-15 Reply to: Probiotics for the Prevention of COVID-19 Sequelae KURIAN, SHILIA JACOB MIRAJ, SONAL SEKHAR Arch Med Res Letter to the Author Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. 2022-09 2022-08-15 /pmc/articles/PMC9376338/ /pubmed/35999061 http://dx.doi.org/10.1016/j.arcmed.2022.08.005 Text en © 2022 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Author KURIAN, SHILIA JACOB MIRAJ, SONAL SEKHAR Reply to: Probiotics for the Prevention of COVID-19 Sequelae |
title | Reply to: Probiotics for the Prevention of COVID-19 Sequelae |
title_full | Reply to: Probiotics for the Prevention of COVID-19 Sequelae |
title_fullStr | Reply to: Probiotics for the Prevention of COVID-19 Sequelae |
title_full_unstemmed | Reply to: Probiotics for the Prevention of COVID-19 Sequelae |
title_short | Reply to: Probiotics for the Prevention of COVID-19 Sequelae |
title_sort | reply to: probiotics for the prevention of covid-19 sequelae |
topic | Letter to the Author |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376338/ https://www.ncbi.nlm.nih.gov/pubmed/35999061 http://dx.doi.org/10.1016/j.arcmed.2022.08.005 |
work_keys_str_mv | AT kurianshiliajacob replytoprobioticsforthepreventionofcovid19sequelae AT mirajsonalsekhar replytoprobioticsforthepreventionofcovid19sequelae |